APC Implantable Pacing Lead-Flange #3260
510(k) K810397
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK810397 | Date15 May 1981 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- DTB
- Device Class
- Class III
- Regulation
- 21 CFR Part 870.3680
- Advisory Committee
- Cardiovascular
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 18 Sep 2026
The APC Implantable Pacing Lead-Flange #3260 is a permanent pacemaker electrode, designed to transmit electrical impulses from an implanted pacemaker to the heart muscle. This device supports cardiac pacing in patients with bradycardia or other rhythm disorders, ensuring regulated heart function through precise stimulation.
This lead is intended for surgical implantation and is classified as a Class III device under FDA regulations. It is supplied sterile and intended for single-use, with a flange design to enhance stability within the heart. The device holds an FDA 510(k) clearance (K810397) under the product code DTB, authorized for use in cardiovascular applications.
Other devices from American Pacemaker Corp.
Questions
AI-generated answers, 18 Sep 2026
What is the primary purpose of the APC Implantable Pacing Lead-Flange #3260 and how does it function within the body?
The APC Implantable Pacing Lead-Flange #3260 is designed to transmit electrical impulses from an implanted pacemaker to the heart muscle, helping regulate heart rhythm in patients with bradycardia or other cardiac rhythm disorders. It achieves this by delivering precise stimulation to the heart, ensuring consistent and controlled contractions.
Is this device intended for reuse or single-use, and how is it supplied?
This device is intended for single-use only and is supplied sterile, ensuring safety and reliability for one-time surgical implantation. It is not designed for reuse, which helps maintain sterility and performance standards.
What distinguishes the flange design of this pacing lead, and why is it important?
The flange design of the APC Implantable Pacing Lead-Flange #3260 enhances stability within the heart during implantation. This feature helps secure the lead in place, reducing the risk of displacement and ensuring reliable electrical contact for consistent pacing performance.
What regulatory pathway was followed for FDA clearance of this device, and what does that mean for its use?
The APC Implantable Pacing Lead-Flange #3260 received FDA 510(k) clearance (K810397) under the product code DTB, with a decision of *Substantially Equivalent* to a predicate device. This means it was determined to have the same intended use and technological characteristics as a previously cleared device, allowing it to be legally marketed in the U.S. for cardiovascular applications.
What types of patients is this lead intended to support, and how does it address their condition?
This lead is intended for patients with bradycardia or other rhythm disorders requiring cardiac pacing. By delivering regulated electrical impulses to the heart muscle, it helps maintain a consistent and healthy heart rate, improving overall cardiac function and quality of life for these patients.